PAVmed Statistics
Share Statistics
PAVmed has 17.37M
shares outstanding. The number of shares has increased by 77.99%
in one year.
| Shares Outstanding | 17.37M |
| Shares Change (YoY) | 77.99% |
| Shares Change (QoQ) | 51.67% |
| Owned by Institutions (%) | 11.97% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 945 |
| FTD / Avg. Volume | 0.57% |
Short Selling Information
The latest short interest is 233.3K, so 1.36% of the outstanding
shares have been sold short.
| Short Interest | 233.3K |
| Short % of Shares Out | 1.36% |
| Short % of Float | 1.43% |
| Short Ratio (days to cover) | 4.45 |
Valuation Ratios
| PE Ratio | 0 |
| Forward PE | -1.66 |
| PS Ratio | 0 |
| Forward PS | 0.1 |
| PB Ratio | 0 |
| P/FCF Ratio | -0.18 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for PAVmed.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.06,
with a Debt / Equity ratio of -0.01.
| Current Ratio | 0.06 |
| Quick Ratio | 0.06 |
| Debt / Equity | -0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.95 |
| Interest Coverage | 988.6 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $76,794,871.79 |
| Profits Per Employee | $819,641,025.64 |
| Employee Count | 39 |
| Asset Turnover | 97.68 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -3.54B |
| Effective Tax Rate | -12.45% |
Stock Price Statistics
The stock price has increased by -67.92% in the
last 52 weeks. The beta is 1.12, so PAVmed's
price volatility has been higher than the market average.
| Beta | 1.12 |
| 52-Week Price Change | -67.92% |
| 50-Day Moving Average | 0.71 |
| 200-Day Moving Average | 0.88 |
| Relative Strength Index (RSI) | 44.81 |
| Average Volume (20 Days) | 165,639 |
Income Statement
In the last 12 months, PAVmed had revenue of 3B
and earned 31.97B
in profits. Earnings per share was 3.3.
| Revenue | 3B |
| Gross Profit | -1.84B |
| Operating Income | -44.49B |
| Net Income | 31.97B |
| EBITDA | -44.49B |
| EBIT | 28.38B |
| Earnings Per Share (EPS) | 3.3 |
Full Income StatementBalance Sheet
The company has 1.19M in cash and 31.86M in
debt, giving a net cash position of -30.68M.
| Cash & Cash Equivalents | 1.19M |
| Total Debt | 31.86M |
| Net Cash | -30.68M |
| Retained Earnings | -254.97B |
| Total Assets | 30.66M |
| Working Capital | -33.28M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -33.55M
and capital expenditures 0, giving a free cash flow of -33.61M.
| Operating Cash Flow | -33.55M |
| Capital Expenditures | n/a |
| Free Cash Flow | -33.61M |
| FCF Per Share | -3.47 |
Full Cash Flow StatementMargins
Gross margin is -61.6%, with operating and profit margins of -1485.38% and 1067.31%.
| Gross Margin | -61.6% |
| Operating Margin | -1485.38% |
| Pretax Margin | 949.15% |
| Profit Margin | 1067.31% |
| EBITDA Margin | -1485.38% |
| EBIT Margin | -1485.38% |
| FCF Margin | -1.12% |
